mirena 20 mikrogramov/24 ur intrauterini dostavni sistem
bayer d.o.o. - levonorgestrel - intrauterini dostavni sistem - levonorgestrel 52 mg / 1 vložek - plastični maternični vložki z dodatkom progestogenov
kyleena 19,5 mg intrauterini dostavni sistem
bayer d.o.o. - levonorgestrel - intrauterini dostavni sistem - levonorgestrel 19,5 mg / 1 sistem - plastični maternični vložki z dodatkom progestogenov
xtandi
astellas pharma europe b.v. - enzalutamid - prostatične neoplazme - endokrini terapija - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
oktreotid teva 10 mg prašek in vehikel za suspenzijo s podaljšanim sproščanjem za injiciranje
oktreotid - prašek in vehikel za suspenzijo s podaljšanim sproščanjem za injiciranje - oktreotid 10 mg / 1 viala - oktreotid
oktreotid teva 20 mg prašek in vehikel za suspenzijo s podaljšanim sproščanjem za injiciranje
oktreotid - prašek in vehikel za suspenzijo s podaljšanim sproščanjem za injiciranje - oktreotid 20 mg / 1 viala - oktreotid
oktreotid teva 30 mg prašek in vehikel za suspenzijo s podaljšanim sproščanjem za injiciranje
oktreotid - prašek in vehikel za suspenzijo s podaljšanim sproščanjem za injiciranje - oktreotid 30 mg / 1 viala - oktreotid
kliogest 2 mg/1 mg filmsko obložene tablete
novo nordisk a/s - estradiol; noretisteronacetat - filmsko obložena tableta - estradiol 2 mg / 1 tableta noretisteronacetat1 mg / 1 tableta; noretisteronacetat 1 mg / 1 tableta - noretisteron in estrogen
novofem filmsko obložene tablete
novo nordisk a/s - estradiol - filmsko obložena tableta - estradiol 1 mg / 1 tableta - noretisteron in estrogen
firmagon
ferring pharmaceuticals a/s - degareliks - prostatične neoplazme - endokrini terapija - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
fulvestrant accord 250 mg raztopina za injiciranje v napolnjeni injekcijski brizgi
fulvestrant - raztopina za injiciranje v napolnjeni injekcijski brizgi - fulvestrant 250 mg / 1 brizga - fulvestrant